Commonwealth Equity Services
HRMY icon

Commonwealth Equity Services’s Harmony Biosciences HRMY Stock Holding History

Commonwealth Equity Services’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$769K Sell
21,108
-198
-0.9% -$6.25K ﹤0.01% 2932
2026
Q1 		$597K Buy
+21,306
New +$699K ﹤0.01% 3064

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Commonwealth Equity Services's HRMY Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Harmony Biosciences (HRMY) stake by 0.93% in Q2 2026, selling an estimated $6.25K and leaving 21,108 shares worth $769K. The position accounts for ﹤0.01% of the portfolio, ranked #2932.

Commonwealth Equity Services first reported a position in HRMY in Q1 2026 and has held it in 2 quarters since. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Commonwealth Equity Services held 21,108 shares of Harmony Biosciences worth $769K as of Q2 2026.
  • Commonwealth Equity Services sold 198 Harmony Biosciences shares in Q2 2026, an estimated $6.25K.
  • Harmony Biosciences made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #2932 holding.
  • Commonwealth Equity Services first reported a position in Harmony Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.